Welcome to our dedicated page for 1933 Inds news (Ticker: TGIFF), a resource for investors and traders seeking the latest updates and insights on 1933 Inds stock.
1933 Industries Inc. reports recurring developments tied to its Nevada cannabis cultivation and production business. The company owns Alternative Medicine Association, its cultivation and production subsidiary serving the medical and adult-use cannabis market in Nevada, and wholesales cannabis flower, pre-rolls and boutique concentrate products under the AMA brand to retail dispensaries across the state.
Company news commonly covers quarterly and annual financial results, gross margin trends, cultivation performance, product demand in the Las Vegas market, and industry conditions such as pricing compression, illicit hemp competition and tourism-related demand. Updates also address capital-structure matters, including unsecured convertible debentures, conversions, repurchases, liquidity needs and business-continuity considerations.
1933 Industries Inc. (CSE:TGIF)(OTCQB:TGIFF) is reminding Debentureholders to vote at an Extraordinary Meeting on August 6, 2021, regarding an amendment to extend the maturity date of its debentures from September 14, 2021 to September 14, 2022.
The meeting will address the necessary delisting of the debentures for regulatory approval. A detailed Management Information Circular has been distributed to Debentureholders due to Covid-19 restrictions, encouraging proxy voting. The company holds a significant portfolio in cannabis consumer goods, with control over cultivation, extraction, and manufacturing.
1933 Industries Inc. (CSE:TGIF)(OTCQB:TGIFF) has convened an extraordinary meeting for holders of its 10% Senior Unsecured Convertible Debentures scheduled for August 6, 2021, at 10:00 a.m. PT. The purpose is to seek approval for amendments to the Debentures, specifically a potential delisting from the Canadian Securities Exchange to facilitate the extension of the maturity date from September 14, 2021 to September 14, 2022. The meeting will be held virtually, and voting by proxy is encouraged due to COVID-19 restrictions.
1933 Industries (CSE:TGIF)(OTCQB:TGIFF) reported its Q3 2021 financial results, marking its first-ever quarter of profitability with net income of $582,673, compared to a loss of $4.7 million in Q3 2020. Revenues increased 32% year-over-year to $3.4 million, driven by robust demand for premium cannabis products. Adjusted EBITDA reached $1.4 million, significantly improving from a loss of $3.1 million last year. Despite a slight 1% revenue decline from the previous quarter, significant cost reductions of 67% led to a gross margin of 73%. The company also expanded its cultivation facility in Nevada.
1933 Industries Inc. (CSE:TGIF)(OTCQB:TGIFF) announced it received approval for an Adult-Use Distribution License in Nevada, allowing direct transportation of cannabis products to wholesale accounts. This approval enhances supply chain efficiency and reduces distribution costs. Additionally, the company launched Level X, a new ultra-craft cannabis brand focusing on exotic strains, starting with the Milk Monkey strain. The brand targets the Las Vegas market and will offer limited-run strains at select dispensaries.
1933 Industries (CSE:TGIF)(OTCQB:TGIFF), a cannabis consumer packaged goods company, announced it will not amend its 10% Senior Unsecured Convertible Debentures due September 14, 2021, extending maturity to September 14, 2022. The existing indenture will remain unchanged. The Company operates two subsidiaries, managing cultivation and manufacturing of cannabis products.
1933 Industries owns 91% of Alternative Medicine Association and 100% of Infused MFG. Their product suite includes various cannabis formats aimed at both medical and recreational users.
1933 Industries Inc. (CSE:TGIF, OTCQB:TGIFF) has announced that holders of its 10% Senior Unsecured Convertible Debentures, due September 14, 2021, voted to extend the maturity date to September 14, 2022. This amendment was approved at an extraordinary meeting. The effective date is pending regulatory approval from the Canadian Securities Exchange. 1933 Industries, a vertically-integrated cannabis company, is focused on cultivating and manufacturing consumer cannabis goods through its subsidiaries.
1933 Industries reported strong Q2 2021 financial results, with revenues reaching $3.4 million, a 27% increase from the prior quarter. The company achieved a gross margin of 57%, significantly reducing its net loss by 78% to $1.4 million. Adjusted EBITDA loss improved by 98% year-over-year. Major advancements included streamlining operations and expanding premium cannabis product offerings, as well as completing a private placement raising $5 million. However, the pandemic's impact on tourism has affected Canna Hemp™ sales.
1933 Industries Inc. has scheduled an extraordinary meeting for debentureholders to vote on extending the maturity date of its 10% Senior Unsecured Convertible Debentures from September 14, 2021, to September 14, 2022. The meeting will take place virtually on April 14, 2021, at 10:00 a.m. (PT). A Management Information Circular detailing the proposed amendments has been sent to debentureholders and is available on SEDAR and the company's website. The Board encourages support for the extension, aiming to strengthen the company's financial position and optimize performance.
1933 Industries Inc. (CSE:TGIF)(OTCQB:TGIFF) has successfully closed a bought deal private placement, raising C$4,955,052 through the sale of 31,820,000 units at C$0.11 each. The offering includes the issuance of warrants with an exercise price of C$0.16 until March 4, 2023. Additionally, $8.2 million of convertible debentures have been converted into shares, improving the company's balance sheet. The financing supports growth strategies and enhances investor confidence in the company’s position in the cannabis sector.
1933 Industries Inc. (CSE: TGIF, OTCQB: TGIFF) has announced a bought deal private placement to raise C$3,500,200 by issuing 31,820,000 units at C$0.11 each. Each unit includes one common share and a warrant exercisable at C$0.16 for 24 months. The funds will support facility expansion and corporate purposes. Closing is expected around March 4, 2021, with an option for underwriters to purchase an additional 13,640,000 units. This financing aims to strengthen the company’s balance sheet and facilitate growth in Nevada's cannabis market.